Search
for
Sort by
Research 30 of 1000+
- Nonsteroidal inhibitors of human type I steroid 5-.alpha.-reductase
- Benzo[<i>c</i>]quinolizin-3-ones: A Novel Class of Potent and Selective Nonsteroidal Inhibitors of Human Steroid 5α-Reductase 1
- Novel Lead Generation through Hypothetical Pharmacophore Three-Dimensional Database Searching: Discovery of Isoflavonoids as Nonsteroidal Inhibitors of Rat 5α-Reductase
- Natural Product-Inspired Bis(trifluoromethyl) Phenyl Hydroxycinnamate Derivatives as Promising Nonsteroidal Inhibitors of Human Steroid 5α-Reductase Type-1: Synthesis, <i>In Vitro</i>, and <i>In Silico</i> Studies
- Natural Product-InspiredBis(trifluoromethyl) PhenylHydroxycinnamate Derivatives as Promising Nonsteroidal Inhibitorsof Human Steroid 5α-Reductase Type-1: Synthesis, <i>InVitro</i>, and <i>In Silico</i> Studies
- Selective non-steroidal inhibitors of 5α-reductase type 1
- Synthesis and Biological Evaluation of 4-(4-(Alkyl-and Phenylaminocarbonyl)benzoyl)benzoic Acid Derivatives as Non-steroidal Inhibitors of Steroid 5α-Reductase Isozymes 1 and 2
- Kinetic analysis of LY320236: competitive inhibitor of type I and non-competitive inhibitor of type II human steroid 5α-reductase
- Synthesis of phenanthridin-3-one derivatives: Non-steroidal inhibitors of steroid 5-α-reductase
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- Caffeic acid N-[3,5-bis(trifluoromethyl)phenyl] amide as a non-steroidal inhibitor for steroid 5α-reductase type 1 using a human keratinocyte cell-based assay and molecular dynamics
- Novel inhibitors of 5α-reductase
- Sulfatase inhibitors: a patent review
- Novel Clove Essential Oil Nanoemulgel Tailored by Taguchi’s Model and Scaffold-Based Nanofibers: Phytopharmaceuticals with Promising Potential as Cyclooxygenase-2 Inhibitors in External Inflammation
- Recent Advances in the Chemistry and Pharmacological Activity of New Steroidal Antiandrogens and 5α-Reductase Inhibitors
- An overview on 5α-reductase inhibitors
- The enzyme and inhibitors of 4-ene-3-oxosteroid 5α-oxidoreductase
- Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Drug safety evaluation of exemestane
- Extensive Challenges and Pending Advances in the Study of 5-Alpha-Reductase Isoenzymes. A Literature Review
- Androgen Receptor Ligands: Agonists and Antagonists
- Targets to treat androgen excess in polycystic ovary syndrome
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Cyclooxygenases in the skin: pharmacological and toxicological implications
- Three orphans one should know: red scalp, red ear and red scrotum syndrome
- Cutaneous drug reactions
- Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
- Alopecia - the search for novel agents continues
- Alopecia in a premenopausal breast cancer woman treated with letrozole and triptorelin